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ABSTRACT
Escherichia coli isolates causing acute pyelonephritis
in 93 children (25% with urinary tract abnormalit-
ies) were tested for nine virulence factors (papC,
papGII, papGIII, sfa ⁄ foc, hlyC, cnf1, iucC, fyuA and
iroN) and their phylogenetic groups were deter-
mined. Isolates lacking papGII were more frequent
among patients with urinary tract abnormalities
(58% vs. 10%, p 0.0003), as were non-virulent
phylogenetic group A isolates (25% vs. 5%,
p 0.043). Pyelonephritis caused by less virulent
E. coli strains was more frequent among patients
with signiﬁcanturinary tract abnormalities. Further
studies are required to determine whether screen-
ing for E. coli virulence factors may help to identify
children warranting anatomical investigations.
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Urinary tract infection (UTI) is the most common
serious bacterial infection during childhood [1]. It
has been estimated that 7% of girls and 2% of
boys will have a UTI before the age of 6 years [2].
Children who have a ﬁrst UTI are frequently
screened for predisposing renal or urinary tract
abnormalities by means of renal sonography and
voiding cystourethrography (VCU) [3]. Children
with high-grade vesicoureteral reﬂux (VUR)
should receive antibacterial chemoprophylaxis
[3]. However, VCU is invasive and yields normal
results in two-thirds of cases [4]; thus, more
convenient methods for predicting VUR would be
valuable.
Uropathogenic Escherichia coli (UPEC) are the
most frequent cause of UTI in children. Most
UPEC strains belong to phylogenetic group B2
and, to a lesser extent, group D [5,6], while
commensal strains belong mainly to group A.
UPEC strains harbour numerous virulence factors
(VFs), some of which are involved in adhesion to
uroepithelial cells [7]. The present study investi-
gated the phylogenetic background and VFs of
E. coli isolates causing acute pyelonephritis
(APN), and determined their relationship to
urinary tract anatomical status in children.
Consecutive patients, aged 3 months to
15 years, with a ﬁrst or secondary episode of
APN diagnosed between January 2004 and March
2006,were included in the study.APNwas deﬁned
as signiﬁcant bacteriuria (>100 000 CFU ⁄mL) with
pyuria (>100 000 leukocytes ⁄mL), fever >38.5C,
and a C-reactive protein level >80 mg ⁄L. Urine
was collected upon admission in a sterile bag, or
with the midstream clean-catch technique when
the patient was able to void voluntarily. Samples
were cultured within 1 h of collection, and the
resulting isolates were stored at )80C until char-
acterisation.
The phylogenetic group (A, B1, B2 or D) of the
E. coli isolates was determined with a triplex PCR
[8]. All E. coli isolates were screened using multi-
plex PCR [9] for nine virulence markers: papC
(P ﬁmbriae); papGII (adhesin PapG class II);
papGIII (adhesin PapG class III); sfa (S ﬁmbriae);
hlyC (haemolysin); cnf1 (cytotoxic necrotising
factor); iucC (aerobactin iron uptake system); fyuA
(yersiniabactin iron uptake system); and iroN
(salmochelin iron uptake system). Renal ultra-
sound examination was performed within 6 days
of admission, and VCU was performed 6–8 weeks
after the onset of UTI. Clinically signiﬁcant
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urinary tract abnormalities consisted of unilateral
or bilateral grade III–V VUR [10] and
obstructions. Univariate analysis was conducted
using OR and the chi-square test or Fisher’s exact
test, with p <0.05 considered to be signiﬁcant.
APN was diagnosed in 93 children (64 girls).
The median ages of the girls and boys were
15 months (range 113 days to 15 years) and
8 months (range 97 days to 13 years), respect-
ively. VCU revealed a normal urinary tract
anatomy in 70 (75%) children, VUR grade I–II in
11 (12%) children, VUR grades III–V in seven
(8%) children, and other obstructive anomalies
in ﬁve (5%) children; the latter involved the
ureteropelvic junction (n = 2), dilated ureter and
hydronephrosis (n = 2), or mega-ureter (n = 1).
The prevalence of the different phylogenetic
groups and VFs among the APN isolates is shown
in Table 1. Phylogenetic group A was associated
signiﬁcantly with urinary tract abnormalities
(25% vs. 5%, p 0.043; OR 6, CI 0.9–43), and had
a negative predictive value of 90%. The absence
of papGII was also associated with urinary tract
abnormalities (58% vs. 10%, p 0.0003; OR 12,
CI 2.5–54) (Table 1), with a sensitivity of 58%, a
speciﬁcity of 90%, a positive predictive value of
47% and a negative predictive value of 94% for
clinically signiﬁcant urinary tract abnormalities.
The use of sterile bags for urine collection is less
speciﬁc than supra-pubic aspiration [3]; however,
Newman et al. [11] suggested that this means of
collection, although not recommended in relevant
guidelines, is reasonably effective. The aetiologi-
cal responsibility of the UPEC isolates for APN in
the present study was supported by the fact that
90% of isolates belonged to virulence groups B2
and D, and by the low (10%) frequency of papGIII,
a gene usually associated with cystitis [7]. One-
third of patients were boys, a frequency similar to
that reported in previous studies using supra-
pubic aspiration or catheterisation [12,13].
Until recently, evaluation of children with UTI
has centred on the search for reﬂux and other
anatomical abnormalities, based on the use of
sonography and VCU [14]. Among the 93 children
in the present study, 5% had urinary tract obstruc-
tions and 20%hadVUR (with 8%having grades III
or V). This is in agreement with studies that
revealed VUR in 20–40% of children with a ﬁrst
episode of febrile UTI [15]. VCU carries a risk of
iatrogenic UTI and involves the use of irradiation;
in addition, most results are normal. Furthermore,
once reﬂux is diagnosed, the value of antibiotic
prophylaxis is uncertain [16,17]. Antimicrobial
prophylaxis for low-grade VUR does not seem to
be beneﬁcial [12], and previous reports have
distinguished between patients with a low risk of
infection (grades I and II) and thosewith a high risk
(grades III–V and obstruction) [10,18]. New and
more convenient predictors of VUR associated
with a high risk of infection are therefore needed.
In the present study, only strains lacking papGII
were more frequent in children with urinary tract
abnormalities than in those with a normal ana-
tomical status, in keeping with a study in adults
[19] and another paediatric study [10]. In the latter
study, the calculated negative predictive value of
the absence of papGII was 67%, compared to 94%
in the present study. In addition to screening
isolates for nine VFs, the present study
also determined the phylogenetic group, and
used more stringent diagnostic criteria for acute
pyelonephritis.
E. coli strains with poor adhesive capacity are
more likely to reach the kidney in patients with
urinary tract abnormalities [7,20]. The risk of UTI
is determined by the balance between host sus-
ceptibility and bacterial virulence. Less virulent
strains belonging to phylogenetic group A were
also revealed by the present study to be more
Table 1. Distribution of virulence factors and phylogenet-
ic groups among 93 Escherichia coli isolates causing acute












n = 12 (%)
Phylogenetic groups
B2 61 (66) 54 (67) 7 (58)
D 23 (25) 21 (26) 2 (17)
A 7 (7) 4 (5)c 3 (25)c
B1 2 (2) 2 (2) 0
Virulence factors
Adhesins
papGII 78 (84) 73 (90)d 5 (42)d
papGIII 9 (10) 6 (7) 3 (25)
papC 83 (89) 74 (91) 9 (75)
sfa ⁄ foc 32 (34) 27 (33) 5 (42)
Toxins
hlyC 40 (43) 36 (44) 4 (33)
cnf1 31 (33) 27 (33) 4 (33)
Siderophore
fyuA 92 (99) 80 (99) 12 (100)
IroN 61 (65) 51 (63) 10 (83)
iucC 90 (97) 80 (99) 10 (83)
aNormal anatomy or unilateral or bilateral vesicoureteral reﬂux (VUR) grade I–II.
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frequent in patients with clinically signiﬁcant
urinary tract abnormalities.
APN caused by E. coli strains belonging to
phylogenetic group A or lacking papGII is a strong
predictor of signiﬁcant urinary tract abnormalities
in children, with a speciﬁcity of 90%, but a
sensitivity of 58%. Recently, the procalcitonin
level was found to be an independent predictor of
VUR, with a speciﬁcity and sensitivity of 44% and
85%, respectively [21].
In conclusion, pyelonephritis caused by less
virulent E. coli strains is more frequent among
patients with signiﬁcant urinary tract abnormal-
ities. Further studies with larger numbers of
children are needed to determine whether screen-
ing for uropathogenic VFs, combined with deter-
mination of procalcitonin levels, might help
to identify children warranting anatomical
evaluation.
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